Effect of anti-epileptic drug therapy on the unborn child

Journal of Clinical Neuroscience

Volumn 21, Issue 5, 2014, Pages 716-721

  Vajda, Frank J E ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Antiepileptic drugs; Cognitive effects; Dose relationships; Epilepsy; Foetal malformations; Pregnancy; Pregnancy registers

Indexed keywords

ANTICONVULSIVE AGENT;

ABNORMALITIES, DRUG-INDUCED; ANIMAL; CHEMICALLY INDUCED; DIAGNOSIS; EPIDEMIOLOGY; EPILEPSY; FEMALE; HUMAN; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL EXPOSURE; TREATMENT OUTCOME;

ABNORMALITIES, DRUG-INDUCED; ANIMALS; ANTICONVULSANTS; EPILEPSY; FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL EXPOSURE DELAYED EFFECTS; TREATMENT OUTCOME;

EID: 84898599872     PISSN: 09675868     EISSN: 15322653     Source Type: Journal    
DOI: 10.1016/j.jocn.2013.09.022     Document Type: Review

References (58)

1. M.J. Eadie Antiepileptic drugs as human teratogens Expert Opin Drug Saf 7 2008 195 209
2. S. Kaneko, D. Battino, and E. Andermann et al. Congenital malformations due to antiepileptic drugs Epilepsy Res 33 1999 145 158
3. E.B. Samren, C.M. Van Duijn, and S. Koch et al. Maternal use of antiepileptic drugs and the risk of major congenital malformations: a joint European prospective study of human teratogenesis associated with maternal epilepsy Epilepsia 38 1997 981 990
4. S. Matalon, S. Scherman, and G. Goldzweig et al. The teratogenic effect of carbamazepine: a meta-analysis of 1255, exposures Reprod Toxicol 16 2002 9 17
5. B. Dalens, E.J. Raynaud, and J. Gaulme Teratogenicity of valproic acid J Paediatr 97 1980 332 333
6. B.D. Speidel, and S.R. Meadow Maternal epilepsy and abnormalities of the fetus and newborn Lancet 2 1972 839 843
7. D. Lindhout, and D. Schmidt In utero exposure to valproate and neural tube defects Lancet 1 1986 1392 1393
8. D. Lindhout, R.J. Hoppener, and H. Meinardi Teratogenicity of antiepileptic drug combinations with special emphasis on epoxidation (of carbamazepine) Epilepsia 25 1984 77 83
9. L.B. Holmes, E.A. Harvey, and B.A. Coull et al. The teratogenicity of anticonvulsant drugs N Engl J Med 344 2001 1132 1138
10. J. Morrow, A. Russell, and E. Guthrie et al. Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register J Neurol Neurosurg Psychiatry 77 2006 193 198
11. F.J. Vajda, A. Hitchcock, and J. Graham et al. Foetal malformations and seizure control: 52 months data of the Australian, Pregnancy Register Eur J Neurol 13 2006 645 654
12. F. Vajda, A. Hitchcock, and J. Graham et al. Seizure control in antiepileptic drug-treated pregnancy Epilepsia 49 2008 172 175
13. E.R. Somerville, M.J. Cook, and T.J. O'Brien Pregnancy treatment guidelines. Throwing the baby out with the bathwater Epilepsia 50 2009 2172
14. D.F. Wyszynski, M. Nambisan, and T. Surve et al. Increased rate of major malformations in offspring exposed to valproate during pregnancy Neurology 64 2005 961 965
15. T. Tomson, D. Battino, and E. Bonizzoni et al. Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry Lancet Neurol 10 2011 609 617
16. EURAP Study Group. Drug Utilization. European Epilepsy Congress, July 2010, Rhodes.
17. F.J. Vajda, T.J. O'Brien, and A. Hitchcock et al. Critical relationship between sodium valproate dose and human teratogenicity: results of the Australian register of anti-epileptic drugs in pregnancy J Clin Neurosci 11 2004 854 858
18. M.J. Eadie, and F.J. Vajda Should valproate be taken during pregnancy? Ther Clin Risk Manage 1 2005 21 26
19. J.C. Dean, H. Hailey, and S.J. Moore et al. Long term health and neurodevelopment in children exposed to antiepileptic drugs before birth J Med Genet 39 2002 251 259
20. Sevulescu J. Personal communication 1999.
21. L.B. Holmes, D.F. Wyszinszky, and E. Lieberman The AED Pregnancy registry, a 6 year experience Arch Neurol 61 2004 673 678
22. K.J. Meador, P.B. Pennell, and G.L. Harden et al. Pregnancy registries in epilepsy: a consensus statement on health outcomes Neurology 71 2008 1109 1117
23. K. Meador, M.W. Reynolds, and S. Crean et al. Pregnancy outcomes in women with epilepsy: a systematic review and meta-analysis of published pregnancy registries and cohorts Epilepsy Res 81 2008 1 13
24. T. Tomson, D. Battino, and J. Caig et al. Pregnancy registries: differences, similarities an possible harmonization Epilepsia 51 2010 909 915
25. F.J. Vajda, T. O'Brien, and A. Hitchcock et al. The Australian antiepileptic drug in pregnancy register: aspects of data collection and analysis J Clin Neurosci 14 2007 936 942
26. F.J. Vajda, T. O'Brien, and A. Hitchcock et al. The Internal control group in a register of antiepileptic drug use in pregnancy J Clin Neurosci 15 2008 29 35
27. F.J. Vajda, A.A. Hitchcock, and J. Graham et al. The teratogenic risk of antiepileptic drug polytherapy Epilepsia 51 2010 805 810
28. MRC Vitamin Study Research Group Prevention of neural tube defects: results of the Medical Research Council Vitamin Study Lancet 338 1991 131 137
29. A.E. Czeizel, and I. Dudas Prevention of the first occurrence of neural tube defects by periconceptual vitamin supplementation N Engl J Med 327 1992 1832 1835
30. J. Craig, P. Morrison, and J. Morrow et al. Failure of periconceptual folic acid to prevent a neural tube defect in the offspring of a mother taking sodium valproate Seizure 8 1999 253 254
31. Vajda F, Graham J, Hitchcock A, et al. Malformation outcome data from the Australian Pregnancy Register. World Congress of Obstetrics Medicine Melbourne 2010 [abstract].
32. Vajda F, Graham J, Hitchcock A, et al. Relative teratogenicity of individual antiepileptic drugs. Epilepsy Society of Australia, Annual Scientific Meeting 2009.
33. Vajda F, Graham J, Hitchcock A, et al. Types of foetal malformations. Data from the Australian Pregnancy Register. World Congress of Obstetrics Medicine Melbourne 2010 [abstract].
34. Vajda FJ, Dose related teratogenicity of valproate. In: 5th international congress, controversies in neurology platform presentation, October 2010, Barcelona, Spain.
35. M.J. Eadie Expert opinion, antiepileptic drugs as human teratogens Expert Opin Drug Saf 7 2008 195 209
36. S. Matalon, S. Schechtman, and G. Goldzweig et al. The teratogenic effect of carbamazepine: a meta analysis of 1255 exposures Reprod Toxicol 16 2002 9 17
37. S.A. Clay, R. McVie, and H. Chen Possible teratogenic effect of valproic acid J Paediatr 99 1981 828
38. B. Robert, and P. Gibaud Maternal valproic acid use and congenital neural tube defects Lancet 2 1982 937
39. Valproate and malformations [editorial]. Lancet 1986;2:1313-4.
40. K. Wide, B. Windbladh, and B. Kallen Major malformations in infants exposed to antiepileptic drugs in utero, with emphasis on carbamazepine and valproic acid: a nation-wide, population-based register study Acta Paedriatr Scand 93 2004 174 176
41. J. Jentink, M.A. Loane, and H. Dolk et al. Valproic acid monotherapy on pregnancy and major congenital malformations N Engl J Med 362 2010 2185 2193
42. F.J.E. Vajda, and T.J. O'Brien Valproic acid use in pregnancy and congenital malformations N Engl J Med 363 2010 1771 1772
43. T. Kondo, S. Kaneko, and Y. Amano et al. Preliminary report on teratogenic effects of zonisamide in the offspring of treated women with epilepsy Epilepsia 37 1996 1242 1244
44. D. Mølgaard-Nielsen, and A. Hviid Newer-generation antiepileptic drugs and the risk of major birth defects JAMA 305 2011 1996 2002
45. Vajda FJ, Graham J, Roten A, et al. Second generation of Antiepileptic Drugs: Report from the Australian Pregnancy Register, Rome, Epilepsy World Congress August 28-Sept 2, 2011, [Abstract].
46. M. Cunnington, and P. Tennis International Lamotrigine Pregnancy Registry Scientific Advisory Committee. Lamotrigine and the risk of malformations in pregnancy Neurology 64 2005 955 969
47. A. Sabers, J.M. Buchholt, and P. Udall et al. Lamotrigine plasma levels reduced by oral contraceptives Epilepsy Res 47 2001 151
48. F.J. Vajda, J. Graham, and A.A. Hitchcock et al. Is lamotrigine a significant human teratogen? Observations from the Australian Pregnancy Register Seizure 19 2010 558 561
49. S. Hunt, A. Russell, and W.H. Smithson et al. Topiramate in pregnancy: preliminary experience from the UK Epilepsy and Pregnancy Register Neurology 71 2008 272 276
50. FDA warning. 11 March 2011. FDA issued a warning around the use of topiramate, often used in the treatment of migraine. Reference on line.
51. M. Artama, A. Auvinen, and T. Raudaskovski et al. Antiepileptic drug use of women with epilepsy and congenital malformations in the offspring Neurology 64 2005 1874 1878
52. G. Montouris Safety of the newer antiepileptic drug oxcarbazepine during pregnancy Curr Med Res Opin 21 2005 693 701
53. L. Long Levetiracetam monotherapy during pregnancy: case series Epilepsy Behav 4 2003 447 448
54. S. Hunt, J. Craig, and A. Russell et al. Levetiracetam in pregnancy: preliminary experience from the UK Epilepsy and Pregnancy Register Neurology 67 2006 1876 1879
55. K.J. Meador, G.A. Baker, and N. Browning et al. Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs N Engl J Med. 360 2009 1597 1605
56. C. Nadebaum, V. Anderson, and F. Vajda et al. The Australian brain and cognition and antiepileptic drugs, study: IQ in school-aged children exposed to sodium valproate and polytherapy J Int Neuropsychol Soc 17 2011 133 142
57. C. Nadebaum, V.A. Anderson, and F. Vajda et al. Language skills of school-aged children prenatally exposed to antiepileptic drugs Neurology 76 2011 719 726
58. K.J. Meador, G.A. Baker, and N. Browning et al. Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD Study): a prospective observational study Lancet Neurol 12 2013 244 252